5-Hydroxytryptamine and the pulmonary circulation: Receptors, transporters and relevance to pulmonary arterial hypertension

British Journal of Pharmacology

Volumn 131, Issue 2, 2000, Pages 161-168

  MacLean, Margaret R ^a   Herve, Philippe ^b   Eddahibi, Saadia ^c   Adnot, Serge ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

5 hydroxytryptamine; 5 hydroxytryptamine transporter; Proliferation; Pulmonary arterial hypertension; Pulmonary circulation; Vasoconstriction

Indexed keywords

AMINOREX; ANOREXIGENIC AGENT; DEXFENFLURAMINE; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LUNG BLOOD VESSEL; LUNG CIRCULATION; LUNG VASOCONSTRICTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; THROMBOCYTE; VASCULAR SMOOTH MUSCLE;

EID: 0033774752     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703570     Document Type: Review

References (76)

1. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group
2. Paradoxical constriction to platelets by arteries from rats with pulmonary hypertension
3. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats
4. Increased turnover of 5-HT in children with pulmonary hypertension secondary to congenital heart disease
5. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets
6. The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature
7. Serotonin receptors subserve only contraction in canine and rat pulmonary arteries and veins
8. Lipid mediator dysregulation in primary pulmonary hypertension
9. Valvular heart disease associated with fenfluramine-phentermine
10. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth
11. Haemodynamic effects of ketanserin either alone or with oxygen in COPD patients with secondary pulmonary hypertension
12. Serotonin uptake and citalopram binding in platelets from patients with chronic pulmonary hypertension
13. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells relationship with the mitogenic action of serotonin
14. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
15. Imbalance between platelet VEGF and PDGF in pulmonary hypertension, effect of prostacyclin therapy
16. Relationship between dexfenfluramine treatment associated changes in serotonin (5-HT) transporter expression and development of hypoxic pulmonary hypertension
17. Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia
18. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats
19. A new role for an old molecule: 5-HT as a mitogen
20. Etiology and pathogenesis of primary pulmonary hypertension: A perspective
21. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo
22. Release of platelet 5-hydroxytryptamine by some anorexic and other sympathomimetics and their acyl derivatives
23. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
24. Signaling pathways mediating induction of the early response genes prostaglandin G/H synthase-2 and egr-1 by serotonin via 5-HT2A receptors
25. Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension
26. Pulmonary vascular remodelling in pulmonary hypertension
27. The pathology of the early and late stages of primary pulmonary hypertension
28. Evidence for increased expression of the r5-HT(1B) receptor in small pulmonary arteries from rats with chronic hypoxic pulmonary hypertension
29. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease
30. Increase plasma 5-HT in primary pulmonary hypertension
31. Elevated plasma serotonin levels in PPH are not related to platelet activation
32. Pulmonary neuroendocrine cells. Their secretory products and their potential role in health and chronic lung disease
33. Aminorex and the pulmonary circulation
34. 5-hydroxytryptamine(1B) receptor antagonist pretreatment prevents the development of chronic hypoxia-induced pulmonary hypertension in rats
35. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation
36. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
37. Association of Tyr phosphorylation of GTPase-activating protein with mitogenic action of serotonin
38. Superoxide as an intermediate signal for serotonin-induced mitogenesis
39. Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cell in culture
40. Organization of the human serotonin transporter gene
41. Cardiopulmonary dysfunction in cirrhosis
42. Endothelin and serotonin in pulmonary hypertension
43. Pulmonary hypertension, anorexigens and 5-hydroxytryptamine: Pharmacological Synergism in action?
44. 1-receptor mediated vasoconstriction in bovine isolated pulmonary arteries: Influences of vascular endothelium and tone
45. 1-like receptor mediated vasoconstriction in human pulmonary artery
46. Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: Changes in pulmonary hypertension
47. Endothelin ETA and ETB receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles
48. 5-hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats
49. Simultaneous effect of p-chloroamphetamine, d-fenfluramine, and reserpine on free blood and stored 5-HT in brain and blood
50. ET(B) receptors mediate vasoconstriction in human pulmonary resistance arteries
51. 1-receptor agonist on central haemodynamics and the coronary circulation
52. Red blood cells play a crucial role in maintaining vascular reactivity to hypoxia in isolated rat lungs
53. Pulmonary hypertension. Anatomic and physiologic correlates
54. Potassium channel diversity in vascular smooth muscle cells
55. 5-HT receptors mediating contraction in human small muscular pulmonary arteries: Importance of the 5-HT(1B) receptor
56. Stimulation of aortic smooth muscle cells mitogenesis by serotonin
57. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32
58. Influence of chronic hypoxia on the contributions of non-inactivating and delayed rectifier K currents to the resting potential and tone of rat pulmonary artery smooth muscle
59. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture
60. EVE and beyond, retro and prospective insights
61. Rat pulmonary circulation after chronic hypoxia: Hemodynamic and structural features
62. Anorexigens and pulmonary hypertension in the United States: Results from the surveillance of North American pulmonary hypertension
63. On the role of serotonin in the pathogenesis of pulmonary hypertension induced by anorectic drugs; an experimental study in the isolated perfused rat lung
64. Hypoxia response elements in the aldose A, enolase 1, and lactate dehydrogenase A gene contain essential binding sites for hypoxia-inducible factor 1
65. Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAS in rat dorsal raphe
66. Chronic hypoxia is associated with delayed rectifier K + current in rat pulmonary arterial cells
67. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
68. Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: Relationship to tone and cyclic nucleotide levels
69. Cell-specific differences in ET-1 system in adjacent layers of main pulmonary artery. A new source of ET-1
70. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension
71. Observations on the pulmonary arterial blood pressure in the cat
72. General involvement of hypoxia-inducible factor I in transcriptional response to hypoxia
73. The mechanism of acute hypoxic pulmonary vasoconstriction: The tale of two channels
74. Synergistic interactions between fenfluramine and phentermine
75. 5-lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension
76. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension